1-155063954-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_005227.3(EFNA4):c.113+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000726 in 1,378,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.3e-7 ( 0 hom. )
Consequence
EFNA4
NM_005227.3 intron
NM_005227.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0300
Publications
0 publications found
Genes affected
EFNA4 (HGNC:3224): (ephrin A4) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 1-155063954-G-A is Benign according to our data. Variant chr1-155063954-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1916633.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFNA4 | NM_005227.3 | c.113+18G>A | intron_variant | Intron 1 of 3 | ENST00000368409.8 | NP_005218.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.26e-7 AC: 1AN: 1378164Hom.: 0 Cov.: 29 AF XY: 0.00000147 AC XY: 1AN XY: 680666 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1378164
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
680666
show subpopulations
African (AFR)
AF:
AC:
0
AN:
28944
American (AMR)
AF:
AC:
0
AN:
33724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24616
East Asian (EAS)
AF:
AC:
0
AN:
32564
South Asian (SAS)
AF:
AC:
0
AN:
76986
European-Finnish (FIN)
AF:
AC:
0
AN:
47998
Middle Eastern (MID)
AF:
AC:
0
AN:
5102
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1071126
Other (OTH)
AF:
AC:
1
AN:
57104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Oct 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.